Ovary and fimbrial stem cells: biology, niche and cancer origins by Ng, Annie & Barker, Nick
The ovarian surface epithelium (OSE) participates in 
cyclic ovulatory rupture and repair throughout repro-
ductive life1 (BOX 1). During each ovulation, the OSE 
at the apex of the ovulatory follicle ruptures to form a 
stigma wound that facilitates oocyte release and is then 
rapidly repaired. Ovulatory stigmas reach diameters of 
170–180 μm in mice2 and up to several millimetres in non-
human primates3. The repair mechanism of the OSE is 
highly robust and efficient, with complete closure of the 
stigma wound achieved within 12 hours to 3 days follow-
ing rupture in mice2,4. This remarkable cyclic regenerative 
capacity of the OSE suggests the existence of resident stem 
cells. During the ovulation process, the fimbria sweeps 
along the surface of the ovary to collect the released oocyte 
for fertilization1. Moreover, repeated exposure of the fim-
bria to the pro-inflammatory follicula r fluid that is released 
during follicular rupture5–7 (BOX 1) may impose an obli-
gate requirement for resident stem cells in the underlyin g 
epitheliu m for cellular replenishment.
Somatic stem cells have been identified in many adult 
epithelial systems, including the gastrointestinal tract8,9, 
the mammary gland10,11, the prostate12 and the oesopha-
gus13,14, as well as in skin and its appendages15–20. In these 
tissues, resident stem cells drive epithelial homeo stasis 
and repair throughout life. To carry out this func-
tion, stem cells have the unique ability to indefinitely 
self-renew and to give rise to one or more specialized 
cells21. Such ‘stemness’ has long been considered to be a 
largely cell-intrinsic property. However, recent evidence 
of injury-driven stem cell plasticity in several organs 
has highlighted the instrumental role of the local niche 
in defining stem cell identity and function in vivo22. 
Indeed, local niche influences can rapidly convert com-
mitted progenitors or even fully differentiated epithelial 
cells into functional stem cells to facilitate tissue repair 
followin g injury22–26.
Understanding the biology of stem cells of the OSE 
and of fimbrial epithelia has been hampered by the lack 
of molecular markers for prospective identification and 
characterization of stem cell populations. This has been 
compounded by the inherent difficulties of isolating 
sufficient epithelia for detailed analyses and by the lack 
of ex vivo methods for long-term culture of OSE and 
fimbrial epithelia (for recent reviews, see REFS 23,27,28). 
Surrogate stemness assays, including long-term DNA 
label retention and side-population enrichment, have been 
employed to identify candidate subsets of epithelial 
cells that display stem-like activities29–33. More recently, 
novel marker genes that were functionally validated by 
fate-mapping studies were used to document the existence 
of stem cells that establish the epithelial cell lineages of 
the ovary and fimbria during development34, as well as 
contributing to lifelong homeostasis and post-ovulatory 
repair of the ovary34,35.
An understanding of the normal biology of stem cells 
in the ovary and fimbria is crucial for deciphering the 
mechanisms underlying ovary dysfunction and tumori-
genesis in humans. Long-lived stem cells are prime 
candidates for the gradual accumulation of the muta-
tion cohort that is required to drive initiation of cancer 
in many adult epithelia24, and the same may be true for 
epithelial ovarian cancer (EOC). The cellular origins 
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Fimbria
The most distal part of the 
fallopian tube (or oviduct in 
non-primates). The fimbria 
comprises finger-like fringes 
that collect the released 
oocyte from the surface of the 
ovary and transport it into the 
uterus for fertilization.
Ovary
A reproductive organ that is 
responsible for the production 
and cyclic release of oocytes. 
In mammals, the ovary is 
present as a pair of glands that 
are attached to the uterus by 
the ovary ligaments.
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Abstract | The mammalian ovary is covered by a single-layered epithelium that undergoes 
rupture and remodelling following each ovulation. Although resident stem cells are 
presumed to be crucial for this cyclic regeneration, their identity and mode of action have 
been elusive. Surrogate stemness assays and in vivo fate-mapping studies using recently 
discovered stem cell markers have identified stem cell pools in the ovary and fimbria that 
ensure epithelial homeostasis. Recent findings provide insights into intrinsic mechanisms 
and local extrinsic cues that govern the function of ovarian and fimbrial stem cells. These 
discoveries have advanced our understanding of stem cell biology in the ovary and fimbria, 
and lay the foundations for evaluating the contribution of resident stem cells to the initiation 
and progression of human epithelial ovarian cancer.
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Follicular fluid
A growth factor-enriched liquid 
that fills the ovarian follicle. 
The composition of the 
follicular fluid dramatically 
changes during folliculogenesis, 
as well as during the various 
stages of the oestrus cycle.
Niche
The supportive local 
environment in which stem 
cells reside. The stem cell niche 
supplies all the extrinsic 
signalling cues that dictate 
stem cell maintenance and 
proliferative activity.
DNA label retention
Introduction of a nucleotide 
analogue (for example, 
5-bromo-2ʹ-deoxyuridine 
(BrdU) or 5-iodo-2ʹ- 
deoxyuridine (IdU)) or labelling 
by genetic means (for example, 
using histone 2B–GFP) for a 
short period, followed by a 
prolonged period in the 
absence of the labelling 
reagent. After several rounds 
of cell division, fast-cycling cells 
rapidly dilute the label, 
whereas quiescent cells retain 
most of the original label. 
These cells are termed 
label-retaining cells.
Side-population enrichment
A flow-cytometry assay that 
discriminates for and enriches 
cell populations that efflux 
fluorescent dyes (for example, 
Hoechst 33342) at a higher 
pace, owing to the expression 
of ATP-binding cassette 
transporter proteins within 
the cell membrane.
Fate-mapping
Permanent labelling of a cell 
type with a reporter marker 
(LacZ or a fluorescent protein) 
that is inherited by its progeny 
upon cellular division, thus 
facilitating analyses of its 
cell-fate decisions and 
behaviour. Also known as 
lineage tracing.
of EOC are controversial36–41. Traditionally, EOC was 
believed to arise from the ovary itself 36,42. Accumulating 
recent evidence, however, has led to a fundamental par-
adigm shift, according to which EOC may be derived 
from extra-ovarian sites, notably the fimbria38,43,44. These 
new insights are altering our views of the aetiolog y 
of EOC and have important implications for future 
research and preventive therapeutic approaches.
In this Review, we summarize the current knowledge 
on epithelial stem cell biology in the ovary and fimbria, 
and the nature of the local stem cell niche components 
in vivo, and speculate on the cell(s) of origin of EOC. 
Finally, we discuss current challenges and research 
directions that may accelerate progress in this relatively 
immature field.
Structure of the OSE and the fimbrial epithelium
The adult mammalian ovary and fallopian tube 
(including the fimbria) are lined by a single-layered 
epithelium that is derived from a common embryonic 
origin in the pluripotent coelomic epithelium45 (FIG. 1). 
Divergent differentiation during development results 
in the ovaries and fallopian tubes having distinct histol-
ogy and phenotypes. In adulthood, the cycling OSE is a 
simple epithelium that remains incompletely committed 
and transitions between a squamous and a cuboidal cell 
shape, depending on positional and oestrus cues (FIG. 1a). 
By contrast, adult fimbrial epithelia are highly differenti-
ated, assuming specialized columnar shapes comprising 
ciliated and secretory cell types that are intercalated with 
rare, basally located cells31 (FIG. 1b). OSE and fimbrial epi-
thelia express common epithelial (for example, keratins) 
and mesenchymal (for example, vimentin) markers1; 
however, their divergence is associated with the selective 
expression of several epithelial differentiation-specific 
proteins31,37,46–49 (FIG. 1).
Despite being generally considered to be anatomi-
cally separate, the ovary and fimbria are in fact contigu-
ous at a narrow isthmus. This ovary–fimbria connection 
is evident in humans (in which it is termed the ovarian 
fimbriae37,40), non-human primates46 and mice34,35 (FIG. 1). 
In mice, the ovary–fimbria connection is located at the 
Box 1 | Cyclic epithelial remodelling in the ovary and fimbria
Cyclic ovarian surface epithelium (OSE) rupture and repair can be broadly divided into three phases: an ovulatory phase; a 
rupture phase; and a repair phase. In the ovulatory phase (see the figure, part a), with impending ovulation, the ovulatory 
follicle becomes hyperaemic as it protrudes above the ovary surface3,34. Sequential actions of the pituitary gonadotropins 
luteinizing hormone (LH) and follicle-stimulating hormone (FSH) trigger the onset of ovulation. The OSE cells and the 
underlying basal lamina (pink dashed line), together with the tunica albuginea and cell layers of the ovulatory follicle 
(which include theca cells, granulosa cells and their basement membranes) undergo proteolysis and degradation156. 
Tissue degradation is spatially restricted at the follicular apex. Cultured OSE cells have the autonomous ability to release 
matrix-digesting proteases, lysosomal enzymes and plasminogen activators and may contribute to follicular disintegration 
in vivo156–159. In the rupture phase (see the figure, part b), follicular wall disintegration and desquamation of OSE cells at the 
follicular apex create a wound stigma in the epithelial barrier, through which the cumulus–oocyte complex is released into 
the periovarian space160. In the repair phase (see the figure, part c), wound stigma closure post-ovulation is achieved by 
cellular proliferation and migration. Increased OSE proliferation has been observed tandem to large follicles4,161, the stigma 
wound periphery34,161 and post-ovulatory corpora lutea4, and at the hilum35. Intriguingly, proliferative repair in response to 
ovulation has not been observed in the primate OSE3,162,163. This has led to the notion that the primate OSE is dispensable 
for post-ovulatory repair162. Nevertheless, mechanical OSE ablation studies have shown that the primate OSE is capable of 
regenerative proliferation163. OSE cells may also contribute to the deposition of a new basal lamina and stromal matrix 
post-ovulation, as exemplified by their intrinsic capacity for de novo synthesis of laminin, collagens (types I, III and IV) and 
extracellular matrix components in culture159,164.
The fimbria also undergoes cyclic remodelling. In humans, there is evidence to suggest that fimbrial epithelium 
proliferates165 and becomes pseudo-stratified at the follicular phase (pre-ovulation) before reverting to a single layer at 
the luteal phase (post-ovulation)166.
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hilum region and is abridged by the ovary ligament, 
which connects the ovary to the uterus and contains 
blood vessels and nerves entering the ovary34. This ovary 
ligament is also lined by a single-layered epithelium, 
which establishes an OSE–ligament–fimbria epithelial 
continuum (FIG. 1c). Whether a ligament continuum also 
exists in other species remains unclear.
Identity of stem cells in the ovary and fimbria
The adult ovary is composed of germ cells (oocytes or 
oogonia) and somatic cells (OSE, granulosa and theca 
cells) that are supported on a stromal mesh (tunica 
albuginea and interstitial cells). Although the existence 
of stem cell pools that establish and maintain germline 
and ovarian somatic cell lineages has been described, 
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Marker OSE Fimbrial epithelium Refs
Keratins (K7, K8, K18 and K19) + + 37
Vimentin + + 37
Calretinin + – 37,46
Cancer antigen 125 (CA125) – + 47
Epithelial cell adhesion molecule (EPCAM) – + 31,37
Epithelial membrane antigen (EMA) – + 37
Oviduct-speciﬁc glycoprotein (OVGP1) – + 48
Paired box 8 (PAX8) – + (secretory type only) 31,49
Tubulin β4 (TUBB4) – + (ciliated type only) 31,49
CD44 + + (basally located cells only) 31
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Figure 1 | The adult human and mouse ovary and associated tissues. The diagrams show the organization and 
anatomy of the adult human and mouse ovary; the fallopian tube (also known as the oviduct), including finger-like fimbria; 
the ovary ligament; and the uterus. A thin bursa membrane encapsulates the mouse ovary but is absent in humans. 
The placement of the ovary ligament differs between humans and mice. In humans, the ovary and the fimbria are 
anatomically contiguous at the ovarian fimbriae, whereas the ovary ligament abridges the ovary–fimbria connection in 
mice. A single-layered epithelium lines the ovary, fimbria and ovary ligament. a | The ovary is entirely encapsulated by the 
ovarian surface epithelium (OSE), which is a single-layered simple epithelium. Compared with other types of epithelial cell, 
the cells of the OSE are uncommitted and express both epithelial and mesenchymal markers. Cells of the OSE adopt 
cuboidal or squamous cell shapes, depending on oestrus cues and on their proximity to a follicle or to a corpus luteum, 
respectively. b | The adult fimbrial epithelium comprises highly differentiated columnar ciliated and secretory epithelial 
cells, and basally located cells that contact the basement membrane. c | In mice, an OSE–ligament–fimbria epithelial 
continuum exists at the ovary hilum; whether this continuum is also present in other mammalian species is unknown. 
The table lists epithelial differentiation-specific markers that are expressed in the OSE37,46, in fimbria31,37,46–49 or in both31,37.
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Cellular quiescence
A reversible, non-dividing cell 
state. Some stem cells are 
quiescent under steady state, 
a property that is believed to 
sustain lifelong tissue 
maintenance and preservation 
of the stem cell compartment.
their identity and precise locations are still the subject 
of much debate.
Germline stem cells. A long-standing dogma posits that 
female mammals are born with a fixed ovarian follicle 
reserve. Several studies50–55 have challenged this dogma 
by finding that the OSE monolayer in adult mice and 
humans contains putative germline stem cells. These 
cells expressed the oocyte-specific mouse VASA homo-
logue MVH (also known as DDX4), could self-propagate 
in vitro and generated new primordial follicles follow-
ing their xenograft onto donor ovarian tissue in vivo. 
Independent studies have failed to reproduce these semi-
nal findings56–59, and the concept of postnatal oogenesis 
has yet to gain universal acceptance. However, the study 
of potentially persisting oogenesis in adult female mam-
mals is an exciting area of reproductive research that 
holds tremendous promise for the treatment of infertilit y 
pathologies.
Granulosa and theca stem cells. No stem cell activity 
has been detected within adult granulosa or theca cell 
lineages. However, early work has described a small 
proportion of adult granulosa cells that display stem-
like characteristics in culture, including the ability to 
divide and form colonies without substrate anchor-
age60. More recently, in vivo fate-mapping studies have 
revealed two distinct somatic subpopulations within 
embryonic mouse ovaries that establish the granulosa 
lineages of the adult medullary and cortical follicles61,62. 
Putative theca precursors have also been identified in 
the ovaries of newborn mice; these cells differentiated 
into mature steroidogenic cells in vitro and rapidly 
invaded the theca layers of follicles within the host ovary 
post-transplantation63.
OSE stem cells. Microarray profiling and immunohisto-
chemical studies have shown that human OSE expresses 
several classical stem cell markers, including NANOG, 
CD44, aldehyde dehydrogenase 1 family member A1 
(ALDH1A1; also known as retinal dehydrogenase 1), 
ALDH1A2, secreted Frizzled-related protein 1 (SFRP1), 
LIM homeobox protein LHX2 and LHX9 (REFS 64,65).
The first evidence of putative stem cells on the ovary 
surface came in 2008, when 5-bromo-2ʹ-deoxyuridine 
(BrdU) or 5-iodo-2ʹ-deoxyuridine (IdU) and 
doxycyclin e-inducible histone 2B–GFP pulse-chase 
surrogate stemness assays were used to identify a sub-
set of stem-like cells in the adult mouse OSE29 (FIG. 2). 
These OSE cells displayed cellular quiescence, DNA label 
retention and enhanced in vitro colony formation29. The 
label-retaining cells also displayed Hoechst 33342 dye-
effluxing cytoprotective capacity, a trait that is believed 
to be specific to stem cells, owing to their intrinsic abil-
ity to have efflux pumps on their membrane. The loca-
tion of these label-retaining OSE cells, juxtaposed at 
ovulatory follicles, suggests that they may participate in 
post-ovulatory wound closure. Subsequently, a subset 
of verapamil-sensitive OSE cells expressing lympho-
cyte antigen 6A2–6E1 (LY6A; also known as SCA1), 
which is a common haematopoietic stem cell marker, 
with Hoechst-effluxing capability was identified in 
adult mouse ovaries32 (FIG. 2). In culture, Ly6a+ cells had 
enhanced sphere-forming abilities and were respon-
sive to transforming growth factor-β1 (TGFβ1) and 
l eukaemia-inhibitory factor (LIF), two growth factors 
that are abundant in follicular fluid32. A role for these 
label-retaining and Ly6a+ OSE cells in epithelial regener-
ation in vivo, however, has not been formally established.
More recently, two studies34,35 used in vivo fate-
mappin g methodologies to provide direct evidence for the 
existence and locations of self-renewing epithelial stem 
cells in the adult mouse ovary. Fluorescence-activated cell 
sorting was used to isolate a subpopulation of OSE cells 
located at the ovary hilum that displayed high ALDH 
activity35 (FIG. 2). ALDH activity, which confers drug 
resistance and cell protection, has been widely used to 
identify potential stem cells in various tissues66. In cul-
ture, Aldh1+ hilum OSE cells generated large epithelial 
spheres at higher frequency and exhibited enhanced 
colony formation compared to their Aldh1– counterparts. 
Expression analyses showed that Aldh1+ cells expressed 
Leu-rich repeat-containing G protein-coupled receptor 5 
(LGR5), a seven-transmembrane receptor that is a facul-
tative component of the WNT receptor complex and is 
expressed by stem cells in various epithelial tissues8,9,16,67–69. 
Lineage tracing with an Lgr5–Cre-knock-in mouse model 
expressing enhanced GFP (Lgr5–egfp–ires–CreERT2) led 
to the conclusion that hilum cells expressing ALDH1 and 
LGR5 are the major OSE stem cell reservoir that supplies 
epithelia l cells to the entire ovary surface in vivo (BOX 2).
Subsequent experiments using the same Lgr5–Cre-
knock-in allele34 challenged the existence of an exclu-
sive Aldh1+Lgr5+ stem cell compartment in the ovary 
hilum. By combining Lgr5 reporter gene profiling and 
endogenous single-molecule mRNA fluorescence in situ 
hybridization (FISH) expression analyses, these studies 
reported multiple clusters of Lgr5+ cells located at inter-
follicular cleft regions throughout the ovary surface, in 
addition to the population at the hilum (FIG. 2). Long-
term lineage marking analyses indicated that both hilum 
and extrahilum Lgr5+ cell populations were capable of 
generating phenotypically distinct epithelial lineages 
over the 16-month reproductive lifetime of the mouse, 
thus formally establishing the entire Lgr5+ cell pool as 
OSE-resident stem cells (BOX 2).
Whether the ovary epithelium contains additional 
stem cell subsets with distinct lineage features remains 
an open question. Definitive answers to such questions 
would require the discovery of specific genes that mark 
putative stem cell pools for isolation and downstream 
characterization, using clonal marking techniques and/ or 
in vivo conditional gene ablation strategies to establish 
stem cell identity.
Interestingly, human OSE cells express LGR5 (REF. 34), 
suggesting that putative LGR5+ stem cells are present 
in the ovaries of other mammalian species. Future 
experimentation relies on a validated antibody against 
human LGR5 that can be used to purify and character-
ize LGR5+ stem cell activity using functional assays, such 
as in vivo regeneration following transplantation and 
in vitro sphere-forming assays.
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Organoids
Three-dimensional cell culture 
structures that recapitulate the 
multipotent cellular 
differentiation and functional 
complexity of the native tissue 
of origin.
Fimbrial stem cells. Fate-mapping studies that formally 
document somatic stem cells in the adult mouse fim-
bria are currently lacking. LGR5 is not expressed in the 
adult mouse fimbria (although human fimbria highly 
expresses LGR5)34. Furthermore, fate-mapping of Lgr5+ 
epithelial cells at the ovary–ligament–fimbria junction 
showed that these cells did not contribute to in vivo 
homeostasis of the fimbria34, suggesting the existence of 
as-yet undiscovered stem cell populations in this tissue.
Several studies have described stem-like epithelial 
cells in the fallopian tube in humans31 and in the oviduct 
in mice30,33, which were concentrated at the fimbriated 
end (FIG. 2). In mice, two phenotypically distinct popula-
tions of stem-like fimbrial epithelial cells, which were 
distinguished by positive33 and negative30 expression of 
mast–stem cell growth factor receptor KIT, were identi-
fied on the basis of long-term label-retention assays. In 
culture, Kit− label-retaining cells, which did not express 
oestrogen or progesterone receptors (ERa−PR−) formed 
self-renewing organoids that contained mature epithelia 
that are normally present in the native distal (ERa+PR−) 
and proximal (ERa+PR+) oviduct30. Remarkably, the 
organoids also expressed progestogen-associated endo-
metrial protein (PAEP; also known as glycodelin), which 
is a marker of mature endometrium30. This suggests that 
the fimbrial label-retaining cells had considerable plas-
ticity ex vivo. In humans, fimbrial stem-like cells were 
identified as tubulin β4 (TUBB4)−, paired box 8 (PAX8)−, 
CD44+ basally-located cells31 that were capable of gen-
erating in vitro spheres that contained differentiated 
Figure 2 | Locations and characteristics of epithelial stem and stem-like cells in the ovarian surface epithelium 
(OSE) and the fimbria. Surrogate stemness assays and in vivo fate-mapping strategies were used to identify populations 
of epithelial stem and stem-like cells on the ovary surface and fimbrial lining. All putative epithelial stem cells were 
identified in the mouse unless indicated otherwise. The figure lists the characteristics of stem and stem-like cells identified 
by either label retention or expression of a specific marker (Leu-rich repeat-containing G protein-coupled receptor 5 
(LGR5), lymphocyte antigen 6A2–6E1 (LY6A), CD44 and aldehyde dehydrogenase (ALDH) family members). Only the Lgr5+ 
populations located at the hilum and extrahilum regions have been formally established to contribute to in vivo OSE 
homeostasis and post-ovulatory regeneration34. The inset in the Lgr5+ box is a schematic representation of clonal 
fate-mapping using the ROSA4 colour lineage reporter34, which demonstrated the involvement of several Lgr5+ stem cells 
in post-ovulatory wound repair. Each coloured (red, RFP; yellow, YFP; cyan, CFP, membranous) clone represents the 
progeny of a single Lgr5+ OSE stem cell. BrdU, 5-bromo-2ʹ-deoxyuridine; CK6B, cytokeratin 6B; EPCAM, epithelial cell 
adhesion molecule; ERa, oestrogen receptor α; H2B, histone 2B; IdU, 5-iodo-2ʹ-deoxyuridine; ITGA6, integrin α6; 
K5, keratin 5; LEF1, lymphoid enhancer-binding factor 1; LIF, leukaemia inhibitory factor; Paep, progestogen-associated 
endometrial protein; PR, progesterone receptor; TGFβ1, transforming growth factor-β1.
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     Lgr5+ cells34
• Located at interfollicular clefts
• Flanked ovulatory wound margins
• Increased proliferative activity at ovulatory sites
• Stemness proven by in vivo fate-mapping
• Execution of lifelong epithelial homeostasis and
 re-epithelialization (16-month trace)  
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• Concentrated at ﬁmbria
• Basally located cells in contact with basement
 membrane
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ciliated (TUBB4+), secretory (PAX8+) and basally located 
(CD44+) epithelia31.
Early Lgr5+ stem cells in somatic lineage specification. 
Expression of LGR5 was first detected in surface and sub-
surface somatic cells in the embryonic day E12.5–E13.5 
ovary anlagen, coincident with female sex determina-
tion34,61. In vivo lineage tracing during this embryonic 
period showed that early Lgr5+ ovarian cells possessed 
lineage-differentiation capabilities, contributing to both 
the future OSE34 and granulosa cell lineages61. Granulosa 
contribution by early Lgr5+ cells was restricted to the 
pre-granulosa lineage of adult cortical follicles, which is 
responsible for folliculogenesis throughout life61. A dis-
tinct forkhead box L2 (Foxl2)+ Lgr5− pool established the 
adult medullary follicles62. In the developing Müllerian 
duct, expression of LGR5 was restricted to the anterior-
most region (that is, the primordia of the oviduct, includ-
ing the fimbria). These early Lgr5+ cells contributed to the 
epithelia of the adult oviduct, including the fimbria, as 
well as the ovary–ligament–fimbria junction at the ovary 
hilum34. Intriguingly, examination of Lgr5-knockout 
female gonads has shown that OSE and granulosa cell 
lineage differentiation proceeds normally in the absence 
of LGR5 (REF. 61). Instead, Lgr5-mutant ovaries had vari-
able degrees of defects in the differentiation of germ cells, 
which do not normally express LGR5 (REF. 61). It is plausi-
ble that the closely related LGR4, which is also expressed 
in ovarian somatic cells61,70, may provide functional 
redundancy with LGR5 during ovary organogenesis.
OSE and fimbrial stem cell regulation
The behaviour of epithelial stem cells is governed by 
a combination of intrinsic programmes and extrinsic 
stimuli derived from the local niche. Perturbation of 
these regulatory cues is instrumental in driving forma-
tion of epithelial cancer in many tissues, including the 
intestine8, stomach9 and skin71.
Currently, little is known about the extrinsic regula-
tion of stem cell fate (for Lgr5+ cells and other potentially 
undiscovered cells) in the ovary and fimbria. However, 
a large body of work has characterized Lgr5+ stem cell-
driven epithelial systems in other tissues. Insights gained 
from these studies may facilitate the identification of 
stem cell niche components and regulatory signals in 
the ovary and fimbria and uncover similarities between 
different epithelia.
The WNT-enriched Lgr5+ stem cell transcriptome. 
Comparative microarray analyses have shown that 
Lgr5+ and Lgr5− cells have distinct transcriptional 
profiles34. Consistent with the role of WNT signalling 
in the maintenance and renewal of adult epithelial 
stem cells20,68,72–74, Lgr5+ OSE stem cells are enriched 
in expression of several WNT signalling compo-
nents, including the WNT ligand WNT4, as well as 
WNT targe t genes axis inhibition 2 (Axin2) and the 
gene encoding tumour necrosis factor receptor fam-
ily member Troy (Tnfrsf19)34 (FIG. 3a). Activation of 
WNT signalling relies on the binding of secreted WNT 
ligands to their Frizzled receptors and to low-density 
lipoprotein receptor-related protein 5 (LRP5)–LRP6 
co-receptor complexes on the cell surface. This leads 
to stabilization and entry of β-catenin into the nucleus 
to induce transcription of target genes through inter-
actions with the T-cell factor (TCF) and lymphoid 
enhancer factor (LEF) transcription factors. Thus, the 
ability to produce their own WNT4 ligands indicates 
that Lgr5+ OSE stem cells have an intrinsic ability to 
regulate their own fate through an autocrine WNT sig-
nalling loop, as has been recently demonstrated for the 
interfollicular epidermis20.
A finely balanced WNT signal strength is crucial 
to achieving optimal stem cell function. For instance, 
overactive WNT signalling in mice leads to adenoma 
and tumour formation in the gastrointestinal tract and 
Box 2 | Ovulatory re‑epithelialization by Lgr5+ ovarian surface epithelium (OSE) stem cells in mice
In mice, follicular rupture can occur anywhere on the ovary surface (whether this is also true in mono-ovulating species 
such as humans or primates remains unexplored). An aldehyde dehydrogenase 1 (Aldh1)+ Leu-rich repeat-containing 
G protein-coupled receptor 5 (Lgr5)+ stem cell pool restricted to the hilum would require massive cell proliferation and 
extensive migration to repair distant ovulatory stigma wounds. This would be no easy feat, given that surface barrier 
continuity is typically restored within days following ovulation in the mouse2,4. Increased proliferation in OSE cells around 
the ovary hilum, which is suggestive of participation in post-ovulatory wound repair, has been reported2,167, although this 
was not confirmed by other studies168,169. There was also no significant difference in the proliferative activity of Lgr5+ stem 
cells at the hilum compared to those at other regions of the ovary34.
Epithelial restoration occurring in a fast and spatially localized manner intuitively seems to favour a model of 
post-ovulatory repair by local, wound-adjacent stem cells. The widespread distribution of Lgr5+ stem cells throughout the 
mouse ovary surface is consistent with a model of rapid and effective re-epithelialization by these cells at the wound 
perimeter. Supporting this notion is the observation that Lgr5+ OSE stem cells at wound stigmas were highly proliferative34. 
During regular tissue homeostasis (that is, in the absence of ovulation), Lgr5+ stem cells were relatively quiescent and had a 
slow cellular turnover. This is consistent with previous reports of negligible levels of proliferation within non-ovulating 
regions in various species2,3,159,163,168. In this context, widespread proliferation of the OSE does not seem to be required 
during homeostatic expansion of the ovary surface associated with folliculogenesis. In response to local ovulatory damage, 
however, Lgr5+ stem cells at OSE sites flanking ovulatory follicles were activated to contribute progeny to repair the 
subsequent stigma wound34. Clonal fate-mapping using the ROSA4 colour lineage reporter has documented the 
recruitment of multiple Lgr5+ OSE stem cells during the re-epithelialization process (FIG. 2). Comprehensive clonal 
lineage-tracing studies carried out in conjunction with real-time cell tracking should help to establish the population 
kinetics and migration patterns of Lgr5+ stem cells onto the rupture wound during homeostatic repair.
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the stomach8,9, and de novo hair follicle morpho genesis 
and formation of hair follicle tumours71, whereas inhi-
bition of WNT causes depletion of intestinal stem cell 
and crypt compartments74. Although it remains unclear 
how internal WNT signals within Lgr5+ OSE  stem cells 
are regulated, Lgr5 (which is a WNT target gene) is 
likely to bind to its secreted R-spondin ligands (RSPO1 
to RSPO4) to augment the OSE WNT signals that are 
initiated by WNT ligands75. At the same time, Troy, 
which is a negative regulator of WNT signalling within 
Lgr5+ stem cells in the intestine and the gastric cor-
pus76,77, might fine-tune the signal strength of WNT 
and RSPO signalling to restrict the OSE stem cell zone. 
Robust WNT–RSPO signalling has been shown to be 
important during embryonic development of the ovary 
anlagen. Females lacking Wnt4 or Rspo1 were born 
with oocyte-depleted masculinized ovaries, indicative 
of an aberrant male phenotypic pathway during ovarian 
somatic cell differentiation78–80. The physiological role 
of Troy could not be ascertained from loss-of-function 
studies, as mice deficient for Troy were viable and 
fertil e, displaying no abnormalities in their ovaries81,82.
Whether a similar WNT-intrinsic programme 
regulates adult fimbrial stem cell function remains 
largely unexplored. Active canonical WNT signallin g 
has been reported in the adult mouse oviduct83. 
Figure 3 | Putative ovarian surface epithelium (OSE) and fimbrial niche locations and signals. a | A schematic of the 
putative OSE and fimbrial stem cell niche is shown. OSE and fimbrial stem cells (dark pink) are in close contact with their 
mature epithelial progeny (pink and purple) and with the underlying follicle. Expulsion of follicular fluid during ovulation 
provides direct contact between follicular milieu and stem cells in the vicinity of the wound. Candidate regulatory niche 
signals emitted from the mature epithelial progeny (epithelial niche) are depicted, as well as the ovulatory follicle with its 
follicular fluid, and surface stroma (non-epithelial niches). In the inset, presumptive stem-niche units comprising OSE cell 
clusters and the underlying follicular structure (follicle or corpus luteum) on the ovary surface are indicated by orange 
arcs; potential stem cell niches at the ovary hilum are indicated by magenta arcs. b | The small intestinal stem cell niche is 
defined by geometrical arrangement of stem cells (dark pink) and their differentiated Paneth cell progeny surrounded by 
mesenchyme at the base of the crypts. Paneth cells and mesenchyme function as intestinal stem cell niches. c | The hair 
follicle stem cell niche is composed of stem cells (dark pink) residing at the outer bulge and hair germ, supported by niche 
signal-producing secondary hair germ, dermal papilla and stem cell progeny in the inner bulge. ALDH1, aldehyde 
dehydrogenase 1; AXIN2, axis inhibition 2; BMP, bone morphogenetic protein; DLL, delta-like protein; EGF, epidermal 
growth factor; ER, oestrogen receptor; FGF, fibroblast growth factor; FSH, follicle-stimulating hormone; FZD, Frizzled; 
HGF, hepatocyte growth factor; KGF, keratinocyte growth factor; KL, KIT ligand; LGR, Leu-rich repeat-containing 
G protein-coupled receptor; LH, luteinizing hormone; PR, progesterone receptor; SFRP, secreted Frizzled-related protein; 
TGFβ, transforming growth factor-β.
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Corpus luteum
The vascularized by-product of 
a recently ruptured follicle. 
Over time, the corpus luteum 
regresses into the centre of the 
ovary to become stromal or 
interstitial tissue.
Epithelial–mesenchymal 
transition
(EMT). A biological process by 
which epithelial cells dissolve 
their tight junctions with one 
another and convert into a free, 
migratory form.
Moreover, human pathological studies have suggested 
a correlation between aberrant WNT signalling activa-
tion and altered fallopian tubal homeostasis84. Together, 
these findings support a role for WNT in fimbrial stem 
cell specification. As in the ovary, WNT–RSPO signal-
ling promotes embryonic Müllerian duct development. 
Mouse Wnt4-mutants lacked a Müllerian duct at birth, 
in addition to having ovary defects78, whereas inactiva-
tion of Wnt9b85 or Wnt7a86 led to absence of the duct or 
partial elongation of the Müllerian duct.
Putative niche components. Niche signals can be sup-
plied by epithelial (that is, the differentiated stem cell 
progeny) and/or non-epithelial sources87. As niche sig-
nals typically function over short distances88, resident 
stem cells are often located close to their niche cells for 
optimal niche-to-stem-cell signal transmission.
The base of the intestinal crypts of Lieberkühn, 
for instance, comprises discrete niche units contain-
ing multipotent Lgr5+ stem cells that are intercalated 
with their antimicrobial peptide-secreting Paneth cell 
progeny and surrounded by mesenchyme (for a recent 
review, see REF. 24). Paneth cells and mesenchyme rep-
resent crucial intestinal niche sources, secreting essen-
tial stemness signals to balance stem cell maintenance 
and differentiation ex vivo and in vivo75,89–93 (FIG. 3b). 
Similarly, each hair follicle represents a discrete stem 
cell niche entity. Multipotent Cd34+K15+Lgr5+ stem 
cells16,18,94 reside within the lower bulge and the hair 
germ and rely on a range of stem cell activation and 
quiescence signals from the inner bulge, hair germ 
and dermal papilla to achieve homeostatic hair follic le 
regeneration (for recent reviews, see REFS  95,96) 
(FIG. 3c).
Using close proximity as a criterion to define stem 
cell niches, candidate niche components of the ovary 
are the mature epithelial progeny of stem cells (epithe-
lial niche), as well as the underlying follicular struc-
ture (the follicle or ovulatory by-product, known as the 
corpus luteum, and its follicular fluid) and the surface 
stroma at the OSE interface (non-epithelial niches) 
(FIG. 3a). The fimbria probably shares some of the OSE 
niche components, given its proximity to the ovary sur-
face during ovulation. Although this is speculative, it 
is thought that the ovary surface may contain several 
interspersed niche units comprising clusters of OSE 
cells and their underlying follicular structures (FIG. 3a). 
Within each unit, OSE stem cells respond to the unique 
set of paracrine cues derived from their epithelial and 
non-epithelial niche components, to achieve the appro-
priate self-renewal and differentiation. A potential 
Aldh1+Lgr5+ stem cell niche at the mouse ovary hilum 
has also recently been identified35 (FIG. 3a).
WNT niche signals. Secreted WNT molecules are puta-
tive paracrine OSE niche factors. In mice, follicular 
granulosa cells and theca cells, as well as lutein cells of 
corpora lutea, express several WNT ligands (WNT2, 
WNT4, WNT5A and WNT11) and WNT antago-
nists (secreted Frizzled-related protein 1 (SFRP1) 
and SFRP4)97 (FIG. 3a). Of note, WNT2 (REFS 98,99) and 
WNT4 (REF. 98) were regulated according to the oestrus 
cycle and showed preferential expression in large fol-
licles and corpora lutea, respectively, and high expres-
sion of SFRP4 occurred in large follicles and in corpora 
lutea100. Likewise, the adult human and mouse OSE 
express the entire repertoire of functional WNT signal-
ling components, including ligands (WNT2, WNT2B, 
WNT4, WNT5A and WNT11), receptors (Frizzled 1 
(FZD1), FZD2, FZD3, FZD4, FZD5, FZD6, FZD7, 
FZD9 and FZD10) and WNT antagonists (SFRP1 and 
SFRP2) to achieve robust OSE autocrine and paracrine 
WNT signalling64,101 (FIG. 3a).
Exactly which WNT or WNTs are the endogenous 
WNT-modulating niche signals for OSE stem cell 
activity is currently unknown. Loss-of-function mouse 
models have failed to provide direct evidence of this: 
Wnt2-null mice have placental defects, and survivin g 
females do not show an ovary defect102, probably 
because of the compensatory function of other WNTs. 
Furthermore, conditional ablation of WNT4 in adult 
granulosa cells (using an Amhr2–Cre driver) efficiently 
blocked folliculogenesis, but a detailed analysis of the 
OSE was lacking97.
TGFβ and bone morphogenetic protein (BMP) niche 
signals. Secreted TGFβ and BMP is another candi-
date paracrine niche signal. The biological effects of 
TGFβ and BMP signalling are mediated by ligand–
receptor interactions at the cell surface, leading to 
nuclear translocation of SMAD transcription factors 
to regulate stemness-promoting genes. TGFβ signal-
ling within the niche has been implicated in epithe-
lial stem cell quiescence and differentiation, as well as 
induction of epithelia l–mesenchymal transition (EMT)103. 
EMT has also been reported to increase expression of 
stemness markers in human mammary epithelial cells 
104. Interestingly, EMT involvement in post-ovulatory 
wound repair is supported by evidence that artificially 
generated scratch wounds were healed by migra-
tory OSE cells in the presence of the EMT inducer 
pro-epiderma l growth factor (EGF)105.
BMP4 or TGFβ1 has been shown to induce EMT 
of OSE cells in vitro106,107. Adult OSE cells, including 
Lgr5+ OSE stem cells, express all known TGFβ and 
BMP receptors (BMPR1A, BMPR1B, BMPR2, TGFβRI 
and TGFβRII) and downstream signalling effectors 
(SMAD1, SMAD5 and SMAD8, and the co-SMAD 
SMAD4), indicating that the ovary epithelium is a 
target of TGFβ and BMP signalling34,108–110 (FIG. 3a). 
Furthermore, disruption of SMAD3 leads to OSE 
hyperproliferation111. Candidate paracrine BMP signals 
emitted from the follicles include BMP2 and BMP7, the 
expression of which in granulosa cells and theca cells, 
respectively, peaked at ovulation, before rapidly dimin-
ishing within lutein cells post-ovulation112 (FIG. 3a). 
Also of potential importance is the expression of all 
three TGFβ isoforms (TGFβ1, TGFβ2 and TGFβ3) at 
the surface stroma at the OSE interface108,109 (FIG. 3a). 
These secreted molecules might gain direct access to 
the adjacent OSE stem cells following breakdown of 
OSE basemen t membranes during ovulation.
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Cancer cell of origin
The cell that sustains the first 
cancer-promoting mutation or 
mutations that initiate tumour 
development.
Follicular fluid milieu. The follicular fluid is a rich 
source of growth factors, steroid hormones and gonado-
tropins, which regulate growth and differentiation 
(FIG. 3a). Expulsion of follicular fluid at the stigma wound 
that is created during ovulation potentially brings the 
regulatory milieu within signal-receiving range of OSE 
stem cells at wound margins. A centripetal morpho-
genetic gradient of follicular fluid milieu arising from 
the wound epicentre probably establishes the bounda-
ries to facilitate spatially targeted re-epithelialization 
at the follicular apex, whereas wound-distant regions 
remain unperturbed and maintain stem cell quiescence. 
Expulsed follicular fluid may also bathe the fimbrial 
fringes at the ovulatory rupture site (FIG. 3a).
During follicular maturation, the composition of the 
follicular fluid milieu, and hence the nature and strength 
of potential niche signals, dramatically changes. Among 
the growth factors that are present in high concentra-
tions in ovulatory follicular fluid, EGF and TGFα105,113–115, 
hepatocyte growth factor116,117, keratinocyte growth fac-
tor116,118 and KIT ligand116 exerted the most potent mito-
genic effects on OSE cells in vitro. Oestrogen, which is 
an OSE mitogen, also reaches peak levels in the follicular 
fluid of ovulatory follicles. A dramatic shift from oestro-
gen to progesterone production occurs post-ovulation in 
the corpus luteum119. As progesterone has been shown to 
exert a growth-inhibitory effect on cultured OSE cells119, 
this steroid hormone may be an important endogenous 
niche signal to prevent OSE overproliferation. Large 
amounts of the gonadotropins luteinizing hormone (LH) 
and follicle-stimulating hormone (FSH) are deposited 
into the ovulatory follicular fluid by the blood circula-
tion; these long-range signals are known to stimulate 
OSE proliferation in vitro and in vivo4,120,121. Importantly, 
the cell-surface receptors for all of these putative growth-
stimulating and growth-inhibitory regulatory factors 
and hormones are present in the OSE and in the fimbrial 
epithelium3,117,122–125. In sheep, expression of FSH and LH 
receptors was highest in OSE overlying large follicles123, 
suggesting that gonadotropins probably exert the strong-
est growth-stimulating effects in receptor-enriched OSE 
cells on top of ovulatory follicles.
Dissection of niche regulatory mechanisms in vivo and 
in vitro. Definitive proof of the existence of the OSE 
and fimbrial stem cell niche, and its characterization, 
awaits genetic studies to decipher the mechanisms that 
control the OSE and Lgr5+ stem cells. In vivo ablation 
strategies targeting the removal of candidate niche cells 
will also provide direct evidence of a role for the niche 
in maintaining Lgr5+ stem cell activities. However, the 
lack of Cre lines to precisely modulate these signalling 
pathways in the ovary remains a major technical barrier 
to such studies.
Recently, advances have been made in growing ovary 
fragments, whole ovaries or oviductal tissues with intact 
basal lamina and follicular structures in an alginate 
hydrogel matrix126–128 or as multicellular spheroids129,130. 
Although the use of these models has facilitated analy-
ses of the function of stem cells within their native 
microenvironments, the main limitation of current 3D 
culture systems is their inability to sustain long-term 
ovary growth and follicle maturation, which precludes 
the study of ovulatory re-epithelialization. An alterna-
tive approach is the development of near-physiological 
Matrigel-based 3D ex vivo culture systems that are capa-
ble of sustaining the long-term growth of functional 
OSE and fimbrial epithelia, for studying the regulation 
of stem cell behaviour in real time. Such culture sys-
tems have achieved considerable success for the intes-
tine75,89, the stomach9, the colon131,132 and the mammary 
gland133. 3D-based culture studies are particularly useful 
for real-time tracking of Lgr5–egfp+ OSE and fimbrial 
stem cells, combined with clonal fate-mapping strate-
gies in a supportive in vitro environment. Aspects of 
Lgr5+ stem cell behaviour — mode and rate of cell divi-
sion, self-renewal and migration properties — during 
regular tissue homeostasis versus in response to ovu-
latory wound repair could easily be studied, as could 
the effects of specific regulatory growth factors and 
hormonal influences on Lgr5+ stem cell characteristics 
and function. It is therefore of paramount importance to 
optimize culture conditions for the long-term growth of 
near-physiological OSE and fimbrial epithelium in vitro.
Stem cells as putative EOC cell(s) of origin
EOC comprises four phenotypically distinct subtypes, 
including serous, endometrioid, mucinous and clear cell 
carcinomas. Depending on their clinicopathology and 
molecular profile, these EOC subtypes can be classified 
as either type I or type II tumours. Slow-growing type I 
tumours, which encompass low-grade serous, low-grade 
endometrioid, clear cell and mucinous carcinomas41, 
are often preceded by a well-recognized OSE precursor 
intermediary in benign or borderline tumours42. They are 
defined by several somatic mutations, including muta-
tions in the genes encoding β-catenin, PTEN, PIK3CA, 
AT-rich interactive domain-containing protein  1A 
(ARID1A), GTPase KRAS, Ser/Thr protein kinase BRAF 
and Ser/ Thr protein phosphatase PPP2R1A41. By con-
trast, type II tumours, comprising high-grade serous, 
high-grade endometrioid, undifferentiated and malig-
nant-mixed carcinomas41, are aggressive and are invari-
ably detected at advanced stages when the disease has 
spread beyond the ovaries. High-grade serous carcinomas 
(HGSCs), which are the most prevalent type II tumours, 
have a unique genetic fingerprint involving mutations 
in the tumour suppressor gene p53, as well as alterations 
in components of the breast cancer type 1 susceptibility 
protein (BRCA1)–BRCA2, RB1, RAS–PI3K and NOTCH 
signalling pathways and the forkhead box protein M1 
(FOXM1) transcription factor network134.
The identity of the transformed EOC precursor(s) 
remains controversial. The central question is whether a 
single precursor cell generates the entire EOC spectrum, 
or whether each EOC subtype is derived from a distinct 
cell and tissue source. Although the long-held paradigm 
posits that EOC is the result of the transformation of an 
OSE cell, recent compelling evidence has suggested that a 
mutant fimbrial cell may be the cancer-initiating culprit 
for some EOCs, notably HGSCs. This OSE versus fimbrial 
cancer cell of origin controversy (BOX 3) has been extensively 
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reviewed elsewhere36–41,43,135. Genetically engineered mouse 
models for the in vivo transformation of OSE35,136–144,145 
or fimbria48,146–148 support a paradigm in which both 
tissues are potential sources of ovarian carcinogenesis.
Epithelial stem cells have been shown to be cells of 
origin in many human epithelial cancers. Their longev-
ity allows for the accumulation of the range of genetic 
mutations that are needed for perturbation of growth 
controls leading to metaplasia and malignant transfor-
mation. The plasticity of transformed stem cells may 
also account for the phenotypic heterogeneity present 
in EOC.
Several epithelial cancers have been shown to origi-
nate from normal stem cells. For example, constitutive 
activation of the WNT pathway through conditional 
deletion of the adenomatous polyposis coli tumour 
suppressor in Lgr5+ stem cells (but not in their t ransit-
amplifying and differentiated progeny), or expressio n of 
the oncogenic β-catenin in Polycomb complex protein 
BMI1- and prominin 1-expressing stem cells, resulted 
in epithelial cell transformation and rapid forma-
tion of adenomas in the mouse small intestine149–151 
and stomach9.
Recently, meta-analysis of human ovarian cancer 
expression microarrays has revealed an EOC tumour 
cluster, designated stem-A (proliferative) and stem-B 
tumours, that expressed markers typical of epithelial stem 
cells, notably LGR5 and CD133 (also known as prom-
inin 1)152. Thus, EOC may have stem-like components. 
Of note, stem-A tumours were linked with poor clini-
cal prognosis and with high expression of p roliferation-
related genes152 and several WNT–planar cell polarity 
(PCP) pathway genes, including the WNT signalling 
receptor gene FZD7, the knockdown of which decreased 
cell proliferation and migration153.
From this perspective, the recent identification of 
LGR5+ cells in healthy OSE and fimbrial epithelium in 
humans has led to speculation regarding their potential 
role as the EOC cell of origin34. A stem-driven cancer- 
initiating scenario may be proposed, by which an initiating 
mutation that is sustained by a stem cell (LGR5+ and/or 
others) leads to its neoplastic transformation and differ-
entiation along several Müllerian tumour lineages (FIG. 4).
Also of potential importance in EOC genesis is the 
identification of an enriched Aldh1+ and Lgr5+ stem cell 
population at the ovary–fimbrial border in the mouse 
ovary hilum35. Compared to their differentiated progeny, 
OSE cells of the ovary hilum show enhanced proliferation 
in vitro and increased transformation potential in vivo 
following inactivation of tumour suppressor genes trans-
formation related protein 53 (Trp53) and Rb1, which are 
often lost in human HGSCs35.
In humans, the ovary–fimbrial border (termed the 
ovarian fimbriae) represents an epithelial transitional 
zone with overlapping OSE and fimbrial marker expres-
sion36,37,40 and a robust stem cell programme65. It is plausi-
ble that regulation of stem cell fate may be less defined in 
this region, making the cells more susceptible to carcino-
genesis. Furthermore, we speculate that combined niche 
signals emitted by the OSE and fimbrial niches enable 
resident stem cells to differentiate into OSE and Müllerian 
tumour lineages. Epithelial transitional zones have been 
implicated as major sources of many epithelial cancers. 
For example, a small population (~40 cells) of cuboidal 
epithelial cells at the squamocolumnar junction of the 
uterine cervix is believed to be the target precursor for 
cervical carcinogenesis154, whereas Barrett’s oesophagus, 
which is a precursor of oesophageal adenocarcinoma, is 
thought to originate from the embryonic-like squamous 
epithelium at the oesophagus–stomach border155.
The availability of the Lgr5–Cre mouse model should 
make it an ideal in vivo platform for evaluating the behav-
iour of ovary-resident Lgr5+ OSE and ovary–fimbrial 
transitional epithelia following conditional targeting 
of key EOC-associated oncogenes and/or tumour sup-
pressor genes. Such a model will directly assess whether 
transformation of an Lgr5+ stem cell is the initial transfor-
mation event that leads to epithelial precancerous lesions 
and ultimately to EOC.
Future directions and outlook
In contrast to many adult epithelia, our understanding 
of stem cell biology in the ovary and fimbria has 
remained frustratingly poor. Until recently, we could only 
Box 3 | Ovary versus fimbria as epithelial ovarian cancer (EOC) source
Traditionally, the ovarian surface epithelium (OSE), or its cortical inclusion cyst, is 
regarded as the sole EOC source (FIG. 4a). The incessant ovulation hypothesis posits 
that the cyclic rupture and repair trauma that is endured by OSE increases cell 
proliferation and consequently accumulation of deleterious somatic mutations170. 
Cortical inclusion cysts form in the superficial ovarian cortex as a result, and exposure 
of the entrapped cyst-lined OSE cells to the activated stromal milieu42 and 
OSE-secreted milieu within the cystic lumen171 causes their transformation (FIG. 4a). 
Unlike many epithelial cancers, in which carcinogenesis is accompanied by a block in 
differentiation, the ovary epithelium undergoes metaplasia to acquire highly complex 
histology that resembles Müllerian duct-derived fallopian tube (serous EOC), 
endometrium (mucinous EOC), endocervix (endometrioid EOC) or vagina (clear cell 
EOC)1 (FIG. 4a). Consistent with the capability of OSE to give rise to the wide EOC 
histological spectrum, ectopic expression of the Müllerian-expressed homeobox genes 
Hoxa9, Hoxa10 and Hoxa11 induced immortalized OSE cells to differentiate along 
Müllerian lineages in vitro172, and subsequent intraperitoneal inoculation of these 
transformed cells generated tumours resembling serous, endometrioid and mucinous 
EOCs, respectively172. Excessive gonadotropin stimulation and repeated exposure to 
the inflammatory factors within follicular fluid were subsequently identified as factors 
contributing to EOC development135.
Failure to identify convincing EOC precursor lesions in the OSE has led to speculation 
that these carcinomas either arise de novo from epithelial inclusion cysts without an 
intermediary lesion42 or are derived from an extra-ovarian source or sources.
An alternative hypothesis posits that many EOCs, notably high-grade serous 
carcinomas (HGSCs), are derived from the fimbria. Pre-neoplastic p53 signature- 
containing lesions termed serous tubal intraepithelial carcinomas (STICs) have been 
identified in the fimbria of carriers of breast cancer 1 (BRCA1) and BRCA2 mutations 
predisposed to ovarian cancer and in patients with sporadic pelvic–ovarian HGSC, 
whose ovary histology was otherwise normal44,173–177. Secretory fimbrial cells have an 
intrinsic delayed response to DNA damage compared to their ciliated counterparts178. 
This trait might make secretory fimbrial cells vulnerable to the accumulation of 
deleterious mutations in their genomes following repeated exposure to the 
pro-inflammatory follicular fluid milieu. The current model of fimbrial involvement in 
HGSC genesis (FIG. 4b) proposes ectopic implantation of abnormal STIC fimbrial cells 
into the ovary stroma as cortical inclusion cysts through the ovulatory rupture stigma 
site39; analogous to the entrapped-OSE model, exposure of the implanted fimbrial 
epithelia to an unfavourable ovary microenvironment leads to HGSC. As a subset of 
HGSC cases showed no fimbrial STIC involvement173,179, the entrapped-OSE model 
might still apply.
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speculate on the existence of somatic stem cells involved 
in post-ovulatory wound repair and remodelling in these 
tissues. With the discovery of LGR5-marked stem cells 
in the ovary, it is now possible to investigate how these 
stem cells execute wound repair and maintain ovary 
homeostasis. Future efforts should focus on character-
izing the OSE stem cell niche components and signals, 
as well as identifying stem cells that are responsible for 
lifelong homeostasis of the adult fimbrial epithelium.
A more comprehensive understanding of nor-
mal stem cell biology in the ovary and fimbria is also 
expected to shed light on the genesis of EOC, which is 
one of the most fatal, yet least understood, reproductive 
malignancies. Of paramount importance will be inves-
tigating the role of LGR5+ cells in EOC initiation. The 
discovery of a transformation-susceptible Aldh1+Lgr5+ 
stem cell niche at the mouse ovary hilum is particularly 
promising. Whether a similar cancer stem cell niche 
exists in humans is unknown, and this warrants future 
investigation. Armed with these new stem cell (and 
potentially cancer stem cell) markers, and recently devel-
oped mouse ovarian cancer models, we are now well 
placed to make important advances in our understand-
ing of ovary and fimbrial epithelial stem cell biology and 
cancer biology in the next decade
The development of near-physiological 3D human 
ovary and fimbrial culture systems and gene-editing tech-
nologies will also provide essential tools for studying ovary 
and fimbrial stem cell biology and for disease modelling. 
Given the immense heterogeneity and complexity of EOC, 
elucidating how stem cells execute tissue repair during 
normal homeostasis, and identifying OSE and fimbrial 
niche components and signals, are crucial steps towards 
understanding how tumours develop in these tissues. 
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Figure 4 | Proposed model of stem cell-driven epithelial ovarian cancer (EOC) carcinogenesis. a | A putative ovarian 
surface epithelium (OSE) stem cell as EOC cell of origin is shown. During incessant ovulation, a normal or mutated OSE 
stem cell (dark pink) at ovulatory wound margins becomes entrapped within the ovary cortex to form a cortical inclusion 
cyst. The entrapped stem cell is exposed to aberrant paracrine signals from the activated stromal niche (orange area) and/or 
autocrine signals within the cystic lumen (grey area). Over time, the entrapped stem cell undergoes Müllerian metaplasia, 
followed by malignant transformation. Depending on the nature of the niche signals and acquisition of critical mutations, 
the transformed OSE stem cell differentiates along different Müllerian lineages to generate the different type I EOC cell 
types. Type II tumours, conversely, arise de novo from cortical inclusion cysts (or from fimbria, see part b). b | A putative 
fimbrial stem cell as high-grade serous carcinoma (HGSC) cell of origin is shown. A stem cell (dark pink) in the fimbria or 
ovarian fimbriae (marked with *) develops a p53 signature, followed by development of serous tubal intraepithelial 
carcinoma (STIC). During ovulation, the STIC cell (or cells) dislodges and becomes entrapped within the ovary cortex to 
form a cortical inclusion cyst. Exposure to the activated stromal niche (orange area) and/or autocrine signals within the 
cystic lumen (grey area) induces HGSC carcinogenesis and metastasis. No Müllerian metaplasia is involved.
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